
Shed and LTR Pharma finalize U.S. launch for ROXUS intranasal spray
A new commercial partnership between Salt Lake City-based Shed and LTR Pharma is set to introduce ROXUS, a rapid-onset intranasal treatment for erectile dysfunction, to the U.S. market. The deal transitions a previous term sheet into a formal framework, positioning the drug as the flagship offering for the Mavrox men's health platform.


























